Dr Janine Jason, MD in Port Orford, OR - Pediatrics

Dr Janine Jason, MD is a Pediatrics physician based in Port Orford, Oregon. Dr Janine Jason is licensed to practice in Oregon (license number MD27487) and her current practice location is 42338 Parkwood Dr, Port Orford, Oregon. She can be reached at her office (for appointments etc.) via phone at (404) 483-1830.

NPI number for Dr Janine Jason is 1568605103 and her current mailing address is 42338 Parkwood Dr, Port Orford, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1568605103.

Contact Information

	Dr Janine Jason, MD
	42338 Parkwood Dr, Port Orford, OR 97465-9528
	(404) 483-1830
	Not Available

Physician's Profile

Full Name	Dr Janine Jason
Gender	Female
Speciality	Pediatrics
Location	42338 Parkwood Dr, Port Orford, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1568605103
Provider Enumeration Date: 04/13/2009
Last Update Date: 04/13/2009

Medical Identifiers

Medical identifiers for Dr Janine Jason such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1568605103	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	G33623 (California)	Secondary
208000000X	Pediatrics	MD27487 (Oregon)	Primary
208000000X	Pediatrics	VL 145 (South Carolina)	Secondary
2080I0007X	Pediatrics - Clinical & Laboratory Immunology	VL 145 (South Carolina)	Secondary
2080P0201X	Pediatrics - Pediatric Allergy/immunology	G33623 (California)	Secondary
2080P0201X	Pediatrics - Pediatric Allergy/immunology	MD27487 (Oregon)	Secondary
2080P0208X	Pediatrics - Pediatric Infectious Diseases	G33623 (California)	Secondary
2080P0208X	Pediatrics - Pediatric Infectious Diseases	MD27487 (Oregon)	Secondary
2080P0208X	Pediatrics - Pediatric Infectious Diseases	VL 145 (South Carolina)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Janine Jason is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Janine Jason, MD 42338 Parkwood Dr, Port Orford, OR 97465-9528 Ph: (404) 483-1830	Dr Janine Jason, MD 42338 Parkwood Dr, Port Orford, OR 97465-9528 Ph: (404) 483-1830

News Archive

LHC Group, Idaho Home Health and Hospice announce definitive agreement

LHC Group, Inc., a national provider of home health and hospice, announced today that it has signed a definitive agreement with Idaho Home Health and Hospice. Founded in 1977, Idaho Home Health and Hospice is a Joint Commission Accredited home health and hospice provider which currently serves 28 counties through 9 locations in the state of Idaho.

Researchers examines working couple's retirement patterns

When retiring, men are more likely than women to move directly from work to retirement, but overall the retirement patterns for dual-income married couples are complex and call for additional considerations in planning for the future, according to a new study from the Mandel School of Applied Social Sciences at Case Western Reserve University.

Theragenics signs agreement with Core Oncology for distribution of TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Core Oncology, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds.

Heart attack patients treated beyond maximum recommended time have increased mortality: Study

An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.

Dr Janine Jason, MD - Pediatrics in Port Orford, OR